23Apr 2022
Germline testing and genetic counselling in prostate cancer

Germline testing and genetic counselling in prostate cancer

Genetic testing for prostate cancer is rapidly growing and is increasingly driven by precision medicine. Rates of germline pathogenic variants have been reported in up to 15% of men with prostate cancer, particularly in metastatic disease. Genetic testing results could uncover options for precision therapy and a spectrum of hereditary cancer-predisposition syndromes with unique clinical features with complex management options. Thus, the pre-test discussion, whether delivered by genetic counsellors or by health-care professionals in hybrid models, involves information on hereditary cancer risk. Understanding precision medicine, personalized cancer risk management and syndrome-related cancer risk management are important to develop collaborative strategies with genetic counselling for optimal care of patients and their families.

  • #urology

Like

Save

Share